Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 5, 2011, Pages 1071-1079

  Wang, Yi ^a,b   Chen, Zongming E ^a   Yaghmai, Vahid ^a   Nikolaidis, Paul ^a   McCarthy, Robert J ^a   Merrick, Laura ^a   Miller, Frank H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

diffusion; pancreas; pancreas MR; pancreas neoplasms; pancreatic endocrine tumor

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; CARCINOMA; CELL DIFFERENTIATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PHANTOMS, IMAGING; RETROSPECTIVE STUDIES;

EID: 79955371843     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22541     Document Type: Article

References (32)

1. Heitz PU, Komminoth P, Perren A, et al. Pancreatic endocrine tumours: introduction. In:, DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and genetics, tumours of endocrine organs. WHO Classification of Tumours. Lyon, France: IARC Press; 2004. p 176-182.
2. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002; 20: 2633-2642. (Pubitemid 34575635)
3. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009; 40: 30-40.
4. Ehehalt F, Saeger HD, Schmidt CM, Grutzmann R,. Neuroendocrine tumors of the pancreas. Oncologist 2009; 14: 456-467.
5. Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: Application of the delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 2010; 34: 300-313.
6. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401. (Pubitemid 44451313)
7. Schnapauff D, Zeile M, Niederhagen MB, et al. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging 2009; 29: 1355-1359.
8. Fattahi R, Balci NC, Perman WH, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 2009; 29: 350-356.
9. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246: 812-822.
10. Gass A, Niendorf T, Hirsch JG,. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 2001; 186 (Suppl 1): S15-23.
11. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
12. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
13. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006; 241: 839-846. (Pubitemid 46190551)
14. Humphries PD, Sebire NJ, Siegel MJ, Olsen OE,. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 2007; 245: 848-854. (Pubitemid 350127356)
15. Muhi A, Ichikawa T, Motosugi U, et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging 2009; 30: 1005-1011.
16. Hayashida Y, Yakushiji T, Awai K, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 2006; 16: 2637-2643. (Pubitemid 44823917)
17. Bakir B, Salmaslioglu A, Poyanli A, Rozanes I, Acunas B,. Diffusion weighted MR imaging of pancreatic islet cell tumors. Eur J Radiol 2010; 74: 214-220.
18. Koh DM, Takahara T, Imai Y, Collins DJ,. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007; 6: 211-224.
19. Herwick S, Miller FH, Keppke AL,. MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol 2006; 187: W472-480.
20. Rha SE, Jung SE, Lee KH, Ku YM, Byun JY, Lee JM,. CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 2007; 62: 371-377. (Pubitemid 46783366)
21. Kim SY, Lee SS, Byun JH, et al. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology 2010; 255: 815-823.
22. Muller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR,. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994; 190: 475-478. (Pubitemid 24044255)
23. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H,. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999; 173: 393-398. (Pubitemid 29347365)
24. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y,. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226: 71-78. (Pubitemid 36163910)
25. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80: 394-424. (Pubitemid 40874886)
26. Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 2007; 13: 187-196. (Pubitemid 46121868)
27. Soga J, Tazawa K,. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer 1971; 28: 990-998.
28. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008; 26: 222-226. (Pubitemid 351754726)
29. Georges PC, Hui JJ, Gombos Z, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1147-1154. (Pubitemid 350255055)
30. Muraoka N, Uematsu H, Kimura H, et al. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging 2008; 27: 1302-1308. (Pubitemid 351770681)
31. Jamali M, Chetty R,. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol 2008; 19: 282-288.
32. Pape UF, Jann H, Muller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008; 113: 256-265.